MVM Partners’s OptiNose OPTN Stock Holding History

MVM Partners’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-973,684	Closed	-$8.91M	–	2
2025 Q1	$8.91M	Hold	973,684	–	–	11.3%	2
2024 Q4	$6.36M	Hold	973,684	–	–	5.11%	3
2024 Q3	$9.53M	Hold	973,684	–	–	10.4%	3
2024 Q2	$15M	Hold	973,684	–	–	15.07%	2
2024 Q1	$21.3M	Hold	973,684	–	–	12.72%	2
2023 Q4	$18.8M	Hold	973,684	–	–	10.94%	2
2023 Q3	$17.8M	Hold	973,684	–	–	11.19%	2
2023 Q2	$17.7M	Hold	973,684	–	–	8.15%	2
2023 Q1	$28M	Hold	973,684	–	–	12.73%	2
2022 Q4	$26.8M	Buy	+973,684	New	+$37M	9.13%	2

MVM Partners's OPTN Position: Q2 2025 in Review

MVM Partners sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 973,684 shares — an estimated $8.91M sold.

MVM Partners first reported a position in OPTN in Q4 2022 and held it in 10 quarters. The position peaked at $28M in Q1 2023. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

MVM Partners reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
MVM Partners sold 973,684 OptiNose shares in Q2 2025, an estimated $8.91M.
MVM Partners first reported a position in OptiNose in Q4 2022 and held it in 10 quarters.
MVM Partners's OptiNose position peaked at $28M in Q1 2023.
0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on MVM Partners's 13F filing for Q2 2025, filed 14 Aug 2025.